Plus: elderberry & flu; FDA rejects Intarcia's micropump; refusing insulin; more
March 14, 2020 : Issue #1033 TOP STORIES - Diabetes News & Research |
|
Letter from the Editor
Many of our long term readers remember the connection that Steve and I have with Dr. Richard Bernstein. Years ago he turned the diabetes world upside down when he challenged the ADA and AMA with his then “revolutionary” idea that a type one patient could manage their diabetes by counting carbs and dosing insulin. This is now the standard of diabetes care.
Now with Coronavirus putting the whole world on hold, another of his ideas is proving to be true.
He has always told us how Sambucol, a liquid extract made from elderberries, was the best treatment for flu symptoms and reducing the severity and length of flu, and this week we have an excerpt from the Journal of Functional Foods that shows he was correct. It's possible this extract may even work for Covid19 symptoms.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
|
Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.
Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.
Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.
Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.
Visit Doctor's Option |
|
|
|
|
Newsflash: FDA rejects Intarcia’s exenatide implanted micropump
The FDA has now rejected Intarcia’s exenatide implanted micropump for the second time, which may likely put an end to the device. Intarcia received a Complete Response Letter from the FDA stating that their exenatide micropump that could be inserted under the skin and provided its GLP-1 medication for 3 or 6 months and eventually for a year, would not be approved at this time. |
TOP STORIES - Diabetes News and Research |
|
| |
|
|
|
| Did You Know? Elderberry Compounds Could Possibly Help Minimize Symptoms for Flu, Study Suggests
A recent study by a group of Chemical and Biomolecular Engineering researchers from the University of Sydney's Faculty of Engineering in Journal of Functional Foods showed that compounds from elderberries can directly inhibit the influenza virus's entry and replication in human cells, and can help strengthen a person's immune response to the virus. The group performed a comprehensive examination of the mechanism by which phytochemicals from elderberries combat influenza infections. What the study has shown us that the common elderberry has a potent direct antiviral effect against the flu virus," said Dr. Golnoosh Torabian, chief researcher. "It inhibits the early stages of infection by blocking key viral proteins responsible for both the viral attachment and entry into the host cells."
The researchers used commercially farmed elderberries, which were turned into a juice serum and were applied to cells before, during, and after they had been infected with the influenza virus. The phytochemicals from the elderberry juice were shown to be effective at stopping the virus infecting the cells, however to the surprise of the researchers; they were even more effective at inhibiting viral propagation at later stages of the influenza cycle when the cells had already been infected with the virus.
Golnoosh Torabian, Peter Valtchev, Qayyum Adil, Fariba Dehghani. Anti-influenza activity of elderberry (Sambucus nigra). Journal of Functional Foods, 2019; 54: 353 DOI: 10.1016/j.jff.2019.01.031
Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004 Mar-Apr;32(2):132-40. |
|
|
| Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters: Mia Flowers, PharmD. Candidate of Florida Agricultural & Mechanical University School of Pharmacy George McConnell, PharmD. Candidate, LECOM School of Pharmacy Mit Suthar, PharmD. Candidate, LECOM School of Pharmacy Sandra Zaki, PharmD Candidate, Florida A&M University |
|
|
|
|
|
| | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
